Analysis of the Assortability of Ophthalmologists Using a Therapy as Part of Routine Medical Care for Patients with Inflammatory Eye Diseases

The problem of diagnosis and treatment of inflammatory eye diseases takes a leading place in Russia and in the world, but the most important thing is the correct choice of treatment methods. Purpose of the work: collection and analysis of data on doctors’ preferences under prescribing therapy in pat...

Full description

Saved in:
Bibliographic Details
Main Authors: I. V. Vorobyeva, M. A. Frolov, Yu. B. Slonimskiy
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2021-10-01
Series:Oftalʹmologiâ
Subjects:
Online Access:https://www.ophthalmojournal.com/opht/article/view/1615
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849240883320324096
author I. V. Vorobyeva
M. A. Frolov
Yu. B. Slonimskiy
author_facet I. V. Vorobyeva
M. A. Frolov
Yu. B. Slonimskiy
author_sort I. V. Vorobyeva
collection DOAJ
description The problem of diagnosis and treatment of inflammatory eye diseases takes a leading place in Russia and in the world, but the most important thing is the correct choice of treatment methods. Purpose of the work: collection and analysis of data on doctors’ preferences under prescribing therapy in patients with inflammatory eye pathology in routine clinical practice. As a result, 5960 clinical cases from 47 Russian cities were analyzed. This article compiles data from October to November 2020. 151 medical researchers were taken part in the participation of the recruitment. Doctors made different diagnoses for referring patients, but significantly more often diagnosis H10.3 was detected — 17.99 % (in 1072 patients). Ophthalmologists preferred to prescribe the following combination of drugs: 1 — antibacterial local, 2 — local antiseptics, 3 — non-steroidal anti-inflammatory local, a combination (antibiotic and glucocorticosteroid), antiallergic in the form of drops of local action. The choice of drugs for inflammatory eye disease is determined by their high efficiency of use for a given disease: antibiotic Signicef® (levofloxacin 0,5 %), nonsteroidal anti-inflammatory drug Broxinac® (bromphenac 0,09 %), fixed combination Kombinil® (ciprofloxacin 0,3 % + dexamethasone 0,1 %), Visallergol® (olopatadine 0,2 %) in the form of topical eye drops.
format Article
id doaj-art-9909fa6bd50445a2a9f41a593a78c836
institution Kabale University
issn 1816-5095
2500-0845
language Russian
publishDate 2021-10-01
publisher Ophthalmology Publishing Group
record_format Article
series Oftalʹmologiâ
spelling doaj-art-9909fa6bd50445a2a9f41a593a78c8362025-08-20T04:00:20ZrusOphthalmology Publishing GroupOftalʹmologiâ1816-50952500-08452021-10-0118356657710.18008/1816-5095-2021-3-566-577795Analysis of the Assortability of Ophthalmologists Using a Therapy as Part of Routine Medical Care for Patients with Inflammatory Eye DiseasesI. V. Vorobyeva0M. A. Frolov1Yu. B. Slonimskiy2Russian Medical Academy of Continuous Professional Education; Peoples’ Friendship University of Russia (RUDN University)Peoples’ Friendship University of Russia (RUDN University)Russian Medical Academy of Continuous Professional EducationThe problem of diagnosis and treatment of inflammatory eye diseases takes a leading place in Russia and in the world, but the most important thing is the correct choice of treatment methods. Purpose of the work: collection and analysis of data on doctors’ preferences under prescribing therapy in patients with inflammatory eye pathology in routine clinical practice. As a result, 5960 clinical cases from 47 Russian cities were analyzed. This article compiles data from October to November 2020. 151 medical researchers were taken part in the participation of the recruitment. Doctors made different diagnoses for referring patients, but significantly more often diagnosis H10.3 was detected — 17.99 % (in 1072 patients). Ophthalmologists preferred to prescribe the following combination of drugs: 1 — antibacterial local, 2 — local antiseptics, 3 — non-steroidal anti-inflammatory local, a combination (antibiotic and glucocorticosteroid), antiallergic in the form of drops of local action. The choice of drugs for inflammatory eye disease is determined by their high efficiency of use for a given disease: antibiotic Signicef® (levofloxacin 0,5 %), nonsteroidal anti-inflammatory drug Broxinac® (bromphenac 0,09 %), fixed combination Kombinil® (ciprofloxacin 0,3 % + dexamethasone 0,1 %), Visallergol® (olopatadine 0,2 %) in the form of topical eye drops.https://www.ophthalmojournal.com/opht/article/view/1615conjunctivitiskeratitistreatmentlocal antibacterial (ab)local antiseptics (as)non-steroidal anti-inflammatory local (nsaids)combination (antibiotic and glucocorticosteroid (gcs))
spellingShingle I. V. Vorobyeva
M. A. Frolov
Yu. B. Slonimskiy
Analysis of the Assortability of Ophthalmologists Using a Therapy as Part of Routine Medical Care for Patients with Inflammatory Eye Diseases
Oftalʹmologiâ
conjunctivitis
keratitis
treatment
local antibacterial (ab)
local antiseptics (as)
non-steroidal anti-inflammatory local (nsaids)
combination (antibiotic and glucocorticosteroid (gcs))
title Analysis of the Assortability of Ophthalmologists Using a Therapy as Part of Routine Medical Care for Patients with Inflammatory Eye Diseases
title_full Analysis of the Assortability of Ophthalmologists Using a Therapy as Part of Routine Medical Care for Patients with Inflammatory Eye Diseases
title_fullStr Analysis of the Assortability of Ophthalmologists Using a Therapy as Part of Routine Medical Care for Patients with Inflammatory Eye Diseases
title_full_unstemmed Analysis of the Assortability of Ophthalmologists Using a Therapy as Part of Routine Medical Care for Patients with Inflammatory Eye Diseases
title_short Analysis of the Assortability of Ophthalmologists Using a Therapy as Part of Routine Medical Care for Patients with Inflammatory Eye Diseases
title_sort analysis of the assortability of ophthalmologists using a therapy as part of routine medical care for patients with inflammatory eye diseases
topic conjunctivitis
keratitis
treatment
local antibacterial (ab)
local antiseptics (as)
non-steroidal anti-inflammatory local (nsaids)
combination (antibiotic and glucocorticosteroid (gcs))
url https://www.ophthalmojournal.com/opht/article/view/1615
work_keys_str_mv AT ivvorobyeva analysisoftheassortabilityofophthalmologistsusingatherapyaspartofroutinemedicalcareforpatientswithinflammatoryeyediseases
AT mafrolov analysisoftheassortabilityofophthalmologistsusingatherapyaspartofroutinemedicalcareforpatientswithinflammatoryeyediseases
AT yubslonimskiy analysisoftheassortabilityofophthalmologistsusingatherapyaspartofroutinemedicalcareforpatientswithinflammatoryeyediseases